Bontoux, C.; Benzaquen, J.; Hofman, V.; Heeke, S.; Hannetel, P.; Capela-Brosseau-Laborde, P.; Marquette, C.-H.; Ilié, M.; Hofman, P.
Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches. J. Pers. Med. 2022, 12, 1651.
https://doi.org/10.3390/jpm12101651
AMA Style
Bontoux C, Benzaquen J, Hofman V, Heeke S, Hannetel P, Capela-Brosseau-Laborde P, Marquette C-H, Ilié M, Hofman P.
Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches. Journal of Personalized Medicine. 2022; 12(10):1651.
https://doi.org/10.3390/jpm12101651
Chicago/Turabian Style
Bontoux, Christophe, Jonathan Benzaquen, Véronique Hofman, Simon Heeke, Paul Hannetel, Pierre Capela-Brosseau-Laborde, Charles-Hugo Marquette, Marius Ilié, and Paul Hofman.
2022. "Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches" Journal of Personalized Medicine 12, no. 10: 1651.
https://doi.org/10.3390/jpm12101651
APA Style
Bontoux, C., Benzaquen, J., Hofman, V., Heeke, S., Hannetel, P., Capela-Brosseau-Laborde, P., Marquette, C.-H., Ilié, M., & Hofman, P.
(2022). Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches. Journal of Personalized Medicine, 12(10), 1651.
https://doi.org/10.3390/jpm12101651